Condition
Bacterial Vaginosis Treatment
Total Trials
2
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Clindamycin
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 1 (1)
Phase 2 (1)
Trial Status
Active Not Recruiting1
Unknown1
Clinical Trials (2)
Research Network
Common Treatments
- Clindamycin1
- Lcfa011
Active Sponsors
- Meilin Zhu, PhD, Massachusetts General Hospital1
- Caroline Mitchell, MD, MPH, Massachusetts General Hospital1
- Massachusetts General Hospital1
- Zagazig University1
Top Investigators
FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY